Response prediction to antidepressants using scalp and source-localized loudness dependence of auditory evoked potential (LDAEP) slopes

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 44, Issue , 2013, Pages 100-107

  Jaworska, Natalia ^a,b   Blondeau, Claude ^a   Tessier, Pierre ^a   Norris, Sandhaya ^a   Fusee, Wendy ^a   Blier, Pierre ^a   Knott, Verner ^a,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b ALBERTA CHILDREN S HOSPITAL RESEARCH INSTITUTE   (Canada)

^c CARLETON UNIVERSITY   (Canada)

Author keywords

Antidepressants; Classification; Loudness dependence of auditory evoked potentials (LDAEP); Major depressive disorder (MDD); Serotonin

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ESCITALOPRAM; PLACEBO;

ADULT; ARTICLE; DRUG RESPONSE; EVOKED AUDITORY RESPONSE; FEMALE; HAMILTON SCALE; HUMAN; LONG TERM CARE; LOUDNESS DEPENDENCE OF AUDITORY EVOKED POTENTIAL; LOW RESOLUTION BRAIN ELECTROMAGNETIC TOMOGRAPHY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONOTHERAPY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

ACOUSTIC STIMULATION; ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LOUDNESS PERCEPTION; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOACOUSTICS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84874529272     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.01.012     Document Type: Article

References (65)

1. Allen J.J., Urry H.L., Hitt S.K., Coan J.A. The stability of resting frontal electroencephalographic asymmetry in depression. Psychophysiology 2004, 41(2):269-280.
2. Beucke J.C., Uhl I., Plotkin M., Winter C., Assion H.J., Endrass T., et al. Serotonergic neurotransmission in early Parkinson's disease: a pilot study to assess implications for depression in this disorder. World J Biol Psychiatry 2010, 11(6):781-787.
3. Blier P., de Montigny C., Chaput Y. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol 1987, 7(6 Suppl.):24S-35S.
4. Blier P., Ward H.E., Tremblay P., Laberge L., Hébert C., Bergeron R. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. Am J Psychiatry 2010, 167(3):281-288.
5. Chatrian G.E., Lettich E., Nelson P.L. Ten percent electrode system for topographic studies of spontaneous and evoked EEG activity. Am J EEG Technol 1985, 25:83-92.
6. Chen T.J., Yu Y.W., Chen M.C., Wang S.Y., Tsai S.J., Lee T.W. Serotonin dysfunction and suicide attempts in major depressives: an auditory event-related potential study. Neuropsychobiology 2005, 52(1):28-36.
7. Danos P., Kasper S., Scholl H.P., Kaiser J., Ruhrmann S., Höflich G., et al. Clinical response to sleep deprivation and auditory-evoked potentials-preliminary results. Pharmacopsychiatry 1994, 27(2):70-71.
8. Debener S., Strobel A., Kürschner K., Kranczioch C., Hebenstreit J., Maercker A., et al. Is auditory evoked potential augmenting/reducing affected by acute tryptophan depletion?. Biol Psychol 2002, 59(2):121-133.
9. Dierks T., Barta S., Demisch L., Schmeck K., Englert E., Kewitz A., et al. Intensity-dependence of auditory evoked potentials (AEPs) as biological marker for cerebral serotonin levels: effects of tryptophan depletion in healthy subjects. Psychopharmacology (Berl) 1999, 146(1):101-107.
10. Fitzgerald P.B., Mellow T.B., Hoy K.E., Segrave R., Cooper N.R., Upton D.J., et al. A study of intensity dependence of the auditory evoked potential (IDAEP) in medicated melancholic and non-melancholic depression. J Affect Disord 2009, 117(3):212-216.
11. Gallinat J., Bottlender R., Juckel G., Munke-Puchner A., Stotz G., Kuss H.J., et al. The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl) 2000, 148(4):404-411.
12. Ghanbari R., El Mansari M., Blier P. Electrophysiological effects of the co-administration of escitalopram and bupropion on rat serotonin and norepinephrine neurons. J Psychopharmacol 2010, 24(1):39-50.
13. Godey B., Schwartz D., de Graaf J.B., Chauvel P., Liégeois-Chauvel C. Neuromagnetic source localization of auditory evoked fields and intracerebral evoked potentials: a comparison of data in the same patients. Clin Neurophysiol 2001, 112(10):1850-1859.
14. Gopal K.V., Bishop C.E., Carney L. Auditory measures in clinically depressed individuals. II. Auditory evoked potentials and behavioral speech tests. Int J Audiol 2004, 43:499-505.
15. Gratton G., Coles M.G., Donchin E. A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol 1983, 55(4):468-484.
16. Guille V., Croft R.J., O'Neill B.V., Illic S., Phan K.L., Nathan P.J. An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline. Hum Psychopharmacol 2008, 23(3):231-241.
17. Hagenmuller F., Hitz K., Darvas F., Kawohl W. Determination of the loudness dependence of auditory evoked potentials: single-electrode estimation versus dipole source analysis. Hum Psychopharmacol 2011, 26(2):147-154.
18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
19. Hegerl U., Gallinat J., Juckel G. Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?. J Affect Disord 2001, 62(1-2):93-100.
20. Hensch T., Wargelius H.L., Herold U., Lesch K.P., Oreland L., Brocke B. Further evidence for an association of 5-HTTLPR with intensity dependence of auditory-evoked potentials. Neuropsychopharmacology 2006, 31:2047-2054.
21. Hensch T., Wargelius H.L., Herold U., Strobel A., Oreland L., Brocke B. Electrophysiological and behavioral correlates of polymorphisms in the transcription factor AP-2beta coding gene. Neurosci Lett 2008, 436:67-71.
22. Jaworska N., Blier P., Fusee W., Knott V. Scalp- and sLORETA-derived loudness dependence of auditory evoked potentials (LDAEPs) in unmedicated depressed males and females and healthy controls. Clin Neurophysiol 2012, 123(9):1769-1778.
23. Juckel G., Molnár M., Hegerl U., Csépe V., Karmos G. Auditory-evoked potentials as indicator of brain serotonergic activity-first evidence in behaving cats. Biol Psychiatry 1997, 41(12):1181-1195.
24. Juckel G., Hegerl U., Molnár M., Csépe V., Karmos G. Auditory evoked potentials reflect serotonergic neuronal activity-a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 1999, 21(6):710-716.
25. Juckel G., Mavrogiorgou P., Bredemeier S., Gallinat J., Frodl T., Schulz C., et al. Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders-a retrospective study. Pharmacopsychiatry 2004, 37(2):46-51.
26. Juckel G., Pogarell O., Augustin H., Mulert C., Muller-Siecheneder F., Frodl T., et al. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clin Psychiatry 2007, 68(8):1206-1212.
27. Juckel G., Hegerl U., Giegling I., Mavrogiorgou P., Wutzler A., Schuhmacher C., et al. Association of 5-HT1B receptor polymorphisms with the loudness dependence of auditory evoked potentials in a community-based sample of healthy volunteers. Am J Med Genet B Neuropsychiatr Genet 2008, 147B(4):454-458.
28. Kähkönen S., Jääskeläinen I.P., Pennanen S., Liesivuori J., Ahveninen J. Acute tryptophan depletion decreases intensity-dependence of auditory evoked magnetic N1/P2 dipole source activity. Psychopharmacology (Berl) 2002, 164(2):221-227.
29. Lam R.W., Hossie H., Solomons K., Yatham L.N. Citalopram and bupropion-SR: combining versus switching in patients with treatment-resistant depression. J Clin Psychiatry 2004, 65(3):337-340.
30. Lee T.W., Yu Y.W., Chen T.J., Tsai S.J. Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression. J Psychiatry Neurosci 2005, 30(3):202-205.
31. Lee I.H., Yang Y.K., Chen P.S., Huang H.C., Yeh T.L., Lu R.B., et al. Loudness dependence of auditory evoked potentials (LDAEP) correlates with the availability of dopamine transporters and serotonin transporters in healthy volunteers-a two isotopes SPECT study. Psychopharmacology (Berl) 2011, 214(3):617-624.
32. Leuchter A.F., Lesser I.M., Trivedi M.H., Rush A.J., Morris D.W., Warden D., et al. An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder. J Psychiatr Pract 2008, 14(5):271-280.
33. Linka T., Müller B.W., Bender S., Sartory G. The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression. Neurosci Lett 2004, 367(3):375-378.
34. Linka T., Müller B.W., Bender S., Sartory G., Gastpar M. The intensity dependence of auditory evoked ERP components predicts responsiveness to reboxetine treatment in major depression. Pharmacopsychiatry 2005, 38(3):139-143.
35. Linka T., Sartory G., Bender S., Gastpar M., Müller B.W. The intensity dependence of auditory ERP components in unmedicated patients with major depression and healthy controls. An analysis of group differences. J Affect Disord 2007, 103(1-3):139-145.
36. Linka T., Sartory G., Gastpar M., Scherbaum N., Müller B.W. Clinical symptoms of major depression are associated with the intensity dependence of auditory event-related potential components. Psychiatry Res 2009, 169(2):139-143.
37. Manjarrez-Gutierrez G., Marquez R.H., Mejenes-Alvarez S.A., Godinez-Lopez T., Hernandez-R J. Functional change of the auditory cortex related to brain serotonergic neurotransmission in type 1 diabetic adolescents with and without depression. World J Biol Psychiatry 2009, 10:877-883.
38. Marcus S.C., Olfson M. National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry 2010, 67(12):1265-1273.
39. Massey A.E., Marsh V.R., McAllister-Williams R.H. Lack of effect of tryptophan depletion on the loudness dependency of auditory event related potentials in healthy volunteers. Biol Psychol 2004, 65(2):137-145.
40. Montgomery S.A., Åsberg S. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389.
41. Mulert C., Juckel G., Augustin H., Hegerl U. Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression. Clin Neurophysiol 2002, 113(10):1566-1572.
42. Mulert C., Jäger L., Propp S., Karch S., Störmann S., Pogarell O., et al. Sound level dependence of the primary auditory cortex: simultaneous measurement with 61-channel EEG and fMRI. Neuroimage 2005, 28(1):49-58.
43. Mulert C., Juckel G., Brunnmeier M., Karch S., Leicht G., Mergl R., et al. Prediction of treatment response in major depression: integration of concepts. J Affect Disord 2007, 98(3):215-225.
44. Nathan P.J., Segrave R., Phan K.L., O'Neill B., Croft R.J. Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. Hum Psychopharmacol 2006, 21(1):47-52.
45. Nelson J.C., Mazure C.M., Jatlow P.I., Bowers M.B., Price L.H. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study. Biol Psychiatry 2004, 55(3):296-300.
46. Norra C., Becker S., Bröcheler A., Kawohl W., Kunert H.J., Buchner H. Loudness dependence of evoked dipole source activity during acute serotonin challenge in females. Hum Psychopharmacol 2008, 23(1):31-42.
47. Oliva J., Leung S., Croft R.J., O'Neill B.V., O'Kane J., Stout J., et al. The loudness dependence auditory evoked potential is insensitive to acute changes in serotonergic and noradrenergic neurotransmission. Hum Psychopharmacol 2010, 25(5):423-427.
48. Oliva J.L., Leung S., Croft R.J., O'Neill B.V., Stout J.C., Nathan P.J. Evidence for sex differences in the loudness dependence of the auditory evoked potential in humans. Hum Psychopharmacol 2011, 26(2):172-176.
49. O'Neill B.V., Croft R.J., Leung S., Guille V., Galloway M., Phan K.L., et al. Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans. Psychopharmacology (Berl) 2006, 188(1):92-99.
50. O'Neill B.V., Guille V., Croft R.J., Leung S., Scholes K.E., Phan K.L., et al. Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans. Hum Psychopharmacol 2008, 23(4):301-312.
51. Paige S.R., Fitzpatrick D.F., Kline J.P., Balogh S.E., Hendricks S.E. Event-related potential amplitude/intensity slopes predict response to antidepressants. Neuropsychobiology 1994, 30(4):197-201.
52. Paige S.R., Hendricks S.E., Fitzpatrick D.F., Balogh S., Burke W.J. Amplitude/intensity functions of auditory event-related potentials predict responsiveness to bupropion in major depressive disorder. Psychopharmacol Bull 1995, 31(2):243-248.
53. Park Y.M., Lee S.H., Kim S., Bae S.M. The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34(2):313-316.
54. Park Y.M., Kim D.W., Kim S., Im C.H., Lee S.H. The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder. Psychopharmacology (Berl) 2011, 213(2-3):625-632.
55. Pascual-Marqui R.D. The sLORETA method: standardized low-resolution brain electromagnetic tomography (sLORETA): technical details. Methods Find Exp Clin 2002, 24(Suppl. D):5-12.
56. Pizzagalli D., Pascual-Marqui R.D., Nitschke J.B., Oakes T.R., Larson C.L., Abercrombie H.C., et al. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry 2001, 158(3):405-415.
57. Rush A.J., Trivedi M.H., Stewart J.W., Nierenberg A.A., Fava M., Kurian B.T., et al. Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry 2011, 168(7):689-701.
58. Segrave R., Nathan P. Pindolol augmentation of selective serotonin reuptake inhibitors: accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression. Hum Psychopharmacol 2005, 20(3):163-174.
59. Segrave R., Croft R.J., Illic S., Luan Phan K., Nathan P.J. Pindolol does not augment central serotonin function increases to citalopram in humans: an auditory evoked potential investigation. Pharmacol Biochem Behav 2006, 85(1):82-90.
60. Simmons J.G., Nathan P.J., Berger G., Allen N.B. Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants. Psychopharmacology (Berl) 2011, 217(1):101-110.
61. Spier S.A. Use of bupropion with SRIs and venlafaxine. Depress Anxiety 1998, 7(2):73-75.
62. Spronk D., Arns M., Barnett K.J., Cooper N.J., Gordon E. An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study. J Affect Disord. 2011, 128(1-2):41-48.
63. Thase M.E. Evaluating antidepressant therapies: remission as the optimal outcome. J Clin Psychiatry 2003, 13:18-25.
64. Uhl I., Gorynia I., Gallinat J., Mulert C., Wutzler A., Heinz A., et al. Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects?. Hum Psychopharmacol 2006, 21(7):463-471.
65. Wutzler A., Winter C., Kitzrow W., Uhl I., Wolf R.J., Heinz A., et al. Loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary auditory cortex. Neuropsychopharmacology 2008, 33(13):3176-3181.